106 related articles for article (PubMed ID: 1938526)
1. Combined radiation therapy, mitomycin C, and 5-fluorouracil for locally recurrent rectal carcinoma: results of a pilot study.
Wong CS; Cummings BJ; Keane TJ; Dobrowsky W; O'Sullivan B; Catton CN
Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1291-6. PubMed ID: 1938526
[TBL] [Abstract][Full Text] [Related]
2. Mitomycin C, 5-fluorouracil and radiation in advanced, locally recurrent rectal cancer.
Dobrowsky W
Br J Radiol; 1992 Feb; 65(770):143-7. PubMed ID: 1540805
[TBL] [Abstract][Full Text] [Related]
3. Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: prognostic factors and long term outcome.
Valentini V; Morganti AG; De Franco A; Coco C; Ratto C; Battista Doglietto G; Trodella L; Ziccarelli L; Picciocchi A; Cellini N
Cancer; 1999 Dec; 86(12):2612-24. PubMed ID: 10594856
[TBL] [Abstract][Full Text] [Related]
4. A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
Glynne-Jones R; Falk S; Maughan TS; Meadows HM; Sebag-Montefiore D
Br J Cancer; 2007 Feb; 96(4):551-8. PubMed ID: 17262086
[TBL] [Abstract][Full Text] [Related]
5. Combined preoperative radiation and mitomycin/5-fluorouracil treatment for locally advanced rectal adenocarcinoma.
Burke SJ; Percarpio BA; Knight DC; Kwasnik EM
J Am Coll Surg; 1998 Aug; 187(2):164-70. PubMed ID: 9704963
[TBL] [Abstract][Full Text] [Related]
6. Preoperative concurrent 5-fluorouracil infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma.
Chan A; Wong A; Langevin J; Khoo R
Int J Radiat Oncol Biol Phys; 1993 Apr; 25(5):791-9. PubMed ID: 8478229
[TBL] [Abstract][Full Text] [Related]
7. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.
Coia L; Hoffman J; Scher R; Weese J; Solin L; Weiner L; Eisenberg B; Paul A; Hanks G
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):161-7. PubMed ID: 8083109
[TBL] [Abstract][Full Text] [Related]
8. "Sandwich" preoperative and postoperative combined chemotherapy and radiation in tethered and fixed rectal cancer: impact of treatment intensity on local control and survival.
Chan AK; Wong AO; Langevin JM; Jenken DA; Khoo R; Heine JA; Buie WD; Johnson DR
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):629-37. PubMed ID: 9112462
[TBL] [Abstract][Full Text] [Related]
9. Combined modality preoperative therapy in poor prognostic rectal adenocarcinoma.
Haghbin M; Sischy B; Hinson J
Radiother Oncol; 1988 Sep; 13(1):75-81. PubMed ID: 3141984
[TBL] [Abstract][Full Text] [Related]
10. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
11. Radiation therapy alone or in combination with chemotherapy in the treatment of residual or inoperable carcinoma of the rectum and rectosigmoid or pelvic recurrence following colorectal surgery. Radiation Therapy Oncology Group study (76-16).
Rominger CJ; Gunderson LL; Gelber RD; Conner N
Am J Clin Oncol; 1985 Apr; 8(2):118-27. PubMed ID: 3914838
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
13. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial.
Budach V; Stuschke M; Budach W; Baumann M; Geismar D; Grabenbauer G; Lammert I; Jahnke K; Stueben G; Herrmann T; Bamberg M; Wust P; Hinkelbein W; Wernecke KD
J Clin Oncol; 2005 Feb; 23(6):1125-35. PubMed ID: 15718308
[TBL] [Abstract][Full Text] [Related]
14. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C.
Cummings BJ; Keane TJ; O'Sullivan B; Wong CS; Catton CN
Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1115-25. PubMed ID: 1938508
[TBL] [Abstract][Full Text] [Related]
15. CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer.
Cai G; Zhu J; Palmer JD; Xu Y; Hu W; Gu W; Cai S; Zhang Z
Radiat Oncol; 2015 Feb; 10():57. PubMed ID: 25889149
[TBL] [Abstract][Full Text] [Related]
16. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.
Lorvidhaya V; Chitapanarux I; Sangruchi S; Lertsanguansinchai P; Kongthanarat Y; Tangkaratt S; Visetsiri E
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1226-32. PubMed ID: 12654431
[TBL] [Abstract][Full Text] [Related]
17. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation.
Valentini V; Coco C; Cellini N; Picciocchi A; Genovesi D; Mantini G; Barbaro B; Cogliandolo S; Mattana C; Ambesi-Impiombato F; Tedesco M; Cosimelli M
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1067-75. PubMed ID: 9539561
[TBL] [Abstract][Full Text] [Related]
18. Preoperative concomitant radiochemotherapy and IORT in locally advanced rectal cancer.
Crucitti F; Sofo L; Ratto C; Battista Doglietto G; Bellantone R; Nucera P; Bossola M; Ranieri R; Perilli W; Azario L
Rays; 1995; 20(2):197-207. PubMed ID: 7480868
[TBL] [Abstract][Full Text] [Related]
19. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
Chakravarthy A; Abrams RA; Yeo CJ; Korman LT; Donehower RC; Hruban RH; Zahurek ML; Grochow LB; O'Reilly S; Hurwitz H; Jaffee EM; Lillemoe KD; Cameron JL
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1089-96. PubMed ID: 11072167
[TBL] [Abstract][Full Text] [Related]
20. High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
Vestermark LW; Jensen HA; Pfeiffer P
Acta Oncol; 2012 Mar; 51(3):311-7. PubMed ID: 22248062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
